JAG1 and cancer: FAS triggers ERK activation and increased the transcriptional activity of JAG1/NOTCH signaling components, suggesting that FAS serves as a novel transcriptional activator of the NOTCH signaling pathway and that apoptosis resistance in OSCC may allow residual cancer cells to remain, causing treatment failure and recurrence.